882 related articles for article (PubMed ID: 31951421)
1. Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering.
Billingsley MM; Singh N; Ravikumar P; Zhang R; June CH; Mitchell MJ
Nano Lett; 2020 Mar; 20(3):1578-1589. PubMed ID: 31951421
[TBL] [Abstract][Full Text] [Related]
2. Orthogonal Design of Experiments for Optimization of Lipid Nanoparticles for mRNA Engineering of CAR T Cells.
Billingsley MM; Hamilton AG; Mai D; Patel SK; Swingle KL; Sheppard NC; June CH; Mitchell MJ
Nano Lett; 2022 Jan; 22(1):533-542. PubMed ID: 34669421
[TBL] [Abstract][Full Text] [Related]
3. Delivery of Plasmid DNA by Ionizable Lipid Nanoparticles to Induce CAR Expression in T Cells.
Prazeres PHDM; Ferreira H; Costa PAC; da Silva W; Alves MT; Padilla M; Thatte A; Santos AK; Lobo AO; Sabino A; Del Puerto HL; Mitchell MJ; Guimaraes PPG
Int J Nanomedicine; 2023; 18():5891-5904. PubMed ID: 37873551
[TBL] [Abstract][Full Text] [Related]
4. In Vitro Engineering Chimeric Antigen Receptor Macrophages and T Cells by Lipid Nanoparticle-Mediated mRNA Delivery.
Ye Z; Chen J; Zhao X; Li Y; Harmon J; Huang C; Chen J; Xu Q
ACS Biomater Sci Eng; 2022 Feb; 8(2):722-733. PubMed ID: 35104103
[TBL] [Abstract][Full Text] [Related]
5. In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism.
Billingsley MM; Gong N; Mukalel AJ; Thatte AS; El-Mayta R; Patel SK; Metzloff AE; Swingle KL; Han X; Xue L; Hamilton AG; Safford HC; Alameh MG; Papp TE; Parhiz H; Weissman D; Mitchell MJ
Small; 2024 Mar; 20(11):e2304378. PubMed ID: 38072809
[TBL] [Abstract][Full Text] [Related]
6. Ionizable Lipid Nanoparticles with Integrated Immune Checkpoint Inhibition for mRNA CAR T Cell Engineering.
Hamilton AG; Swingle KL; Joseph RA; Mai D; Gong N; Billingsley MM; Alameh MG; Weissman D; Sheppard NC; June CH; Mitchell MJ
Adv Healthc Mater; 2023 Dec; 12(30):e2301515. PubMed ID: 37602495
[TBL] [Abstract][Full Text] [Related]
7. Lipid nanoparticles outperform electroporation in mRNA-based CAR T cell engineering.
Kitte R; Rabel M; Geczy R; Park S; Fricke S; Koehl U; Tretbar US
Mol Ther Methods Clin Dev; 2023 Dec; 31():101139. PubMed ID: 38027056
[TBL] [Abstract][Full Text] [Related]
8. Engineered exosome-mediated messenger RNA and single-chain variable fragment delivery for human chimeric antigen receptor T-cell engineering.
Si K; Dai Z; Li Z; Ye Z; Ding B; Feng S; Sun B; Shen Y; Xiao Z
Cytotherapy; 2023 Jun; 25(6):615-624. PubMed ID: 36828738
[TBL] [Abstract][Full Text] [Related]
9. Lipid Nanoparticle Formulations for Enhanced Co-delivery of siRNA and mRNA.
Ball RL; Hajj KA; Vizelman J; Bajaj P; Whitehead KA
Nano Lett; 2018 Jun; 18(6):3814-3822. PubMed ID: 29694050
[TBL] [Abstract][Full Text] [Related]
10. Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells.
Patel SK; Billingsley MM; Frazee C; Han X; Swingle KL; Qin J; Alameh MG; Wang K; Weissman D; Mitchell MJ
J Control Release; 2022 Jul; 347():521-532. PubMed ID: 35569584
[TBL] [Abstract][Full Text] [Related]
11. Ionizable lipid nanoparticles encapsulating barcoded mRNA for accelerated in vivo delivery screening.
Guimaraes PPG; Zhang R; Spektor R; Tan M; Chung A; Billingsley MM; El-Mayta R; Riley RS; Wang L; Wilson JM; Mitchell MJ
J Control Release; 2019 Dec; 316():404-417. PubMed ID: 31678653
[TBL] [Abstract][Full Text] [Related]
12. A fluorinated ionizable lipid improves the mRNA delivery efficiency of lipid nanoparticles.
Huo H; Cheng X; Xu J; Lin J; Chen N; Lu X
J Mater Chem B; 2023 May; 11(19):4171-4180. PubMed ID: 37129135
[TBL] [Abstract][Full Text] [Related]
13. Lipid Nanoparticle-mRNA Formulations for Therapeutic Applications.
Wang C; Zhang Y; Dong Y
Acc Chem Res; 2021 Dec; 54(23):4283-4293. PubMed ID: 34793124
[TBL] [Abstract][Full Text] [Related]
14. CAR-NK Cells Generated with mRNA-LNPs Kill Tumor Target Cells In Vitro and In Vivo.
Golubovskaya V; Sienkiewicz J; Sun J; Zhang S; Huang Y; Zhou H; Harto H; Xu S; Berahovich R; Wu L
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686170
[TBL] [Abstract][Full Text] [Related]
15. Developing Biodegradable Lipid Nanoparticles for Intracellular mRNA Delivery and Genome Editing.
Qiu M; Li Y; Bloomer H; Xu Q
Acc Chem Res; 2021 Nov; 54(21):4001-4011. PubMed ID: 34668716
[TBL] [Abstract][Full Text] [Related]
16. Lipid nanoparticle-based mRNA candidates elicit potent T cell responses.
Zeng Y; Escalona-Rayo O; Knol R; Kros A; Slütter B
Biomater Sci; 2023 Jan; 11(3):964-974. PubMed ID: 36537916
[TBL] [Abstract][Full Text] [Related]
17. Research advance in lipid nanoparticle-mRNA delivery system and its application in CAR-T cell therapy.
Ye B; Hu Y; Zhang M; Huang H
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 51(2):185-191. PubMed ID: 36161298
[TBL] [Abstract][Full Text] [Related]
18. Chemistry of Lipid Nanoparticles for RNA Delivery.
Eygeris Y; Gupta M; Kim J; Sahay G
Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
[TBL] [Abstract][Full Text] [Related]
19. CAR T cells produced in vivo to treat cardiac injury.
Rurik JG; Tombácz I; Yadegari A; Méndez Fernández PO; Shewale SV; Li L; Kimura T; Soliman OY; Papp TE; Tam YK; Mui BL; Albelda SM; Puré E; June CH; Aghajanian H; Weissman D; Parhiz H; Epstein JA
Science; 2022 Jan; 375(6576):91-96. PubMed ID: 34990237
[TBL] [Abstract][Full Text] [Related]
20. A Combinatorial Library of Lipid Nanoparticles for Cell Type-Specific mRNA Delivery.
Naidu GS; Yong SB; Ramishetti S; Rampado R; Sharma P; Ezra A; Goldsmith M; Hazan-Halevy I; Chatterjee S; Aitha A; Peer D
Adv Sci (Weinh); 2023 Jul; 10(19):e2301929. PubMed ID: 37092557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
